JP2004523556A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004523556A5 JP2004523556A5 JP2002567294A JP2002567294A JP2004523556A5 JP 2004523556 A5 JP2004523556 A5 JP 2004523556A5 JP 2002567294 A JP2002567294 A JP 2002567294A JP 2002567294 A JP2002567294 A JP 2002567294A JP 2004523556 A5 JP2004523556 A5 JP 2004523556A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- group
- composition
- phenyl
- schizophrenia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27188901P | 2001-02-27 | 2001-02-27 | |
| PCT/US2002/006119 WO2002067927A1 (en) | 2001-02-27 | 2002-02-21 | Carbamate compounds for use in preventing or treating psychotic disorders |
| US10/081,761 US6541513B2 (en) | 2001-02-27 | 2002-02-21 | Carbamate compounds for use in preventing or treating psychotic disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004523556A JP2004523556A (ja) | 2004-08-05 |
| JP2004523556A5 true JP2004523556A5 (cg-RX-API-DMAC7.html) | 2005-12-22 |
| JP4276841B2 JP4276841B2 (ja) | 2009-06-10 |
Family
ID=26765939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002567294A Expired - Lifetime JP4276841B2 (ja) | 2001-02-27 | 2002-02-21 | 精神病性障害の予防もしくは治療における使用のためのカルバメート化合物 |
Country Status (25)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL365701A1 (en) * | 2000-07-21 | 2005-01-10 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| WO2003007934A1 (en) | 2001-07-16 | 2003-01-30 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| MXPA03007720A (es) | 2001-02-27 | 2004-11-12 | Johnson & Johnson | Compuestos de carbamato para su uso en la prevencion o el tratamiento de transtornos de ansiedad. |
| DE60220043T2 (de) * | 2001-02-27 | 2008-01-10 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamatverbindungen zur vorbeugung oder behandlung von neurodegenerativen störungen |
| EP1744750A2 (en) * | 2004-05-06 | 2007-01-24 | Sandoz AG | Pharmaceutical composition comprising hydrophobic drug having improved solubility |
| EP1928451B1 (en) * | 2005-07-26 | 2011-12-28 | SK Biopharmaceuticals Co., LTD | Methods for treating substance-related disorders |
| CN101568362A (zh) * | 2006-10-30 | 2009-10-28 | 詹森药业有限公司 | 治疗抑郁症的方法 |
| JP2010508354A (ja) * | 2006-10-31 | 2010-03-18 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 広汎性発達障害の処置 |
| US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
| JP6062077B2 (ja) | 2013-03-12 | 2017-01-18 | バイオ−ファーム ソリューションズ カンパニー リミテッド | 小児てんかん及びてんかん関連症侯群の予防又は治療用フェニルカルバメート化合物{phenylcarbamatecompoundsforuseinpreventingortreatingpediatricepilesyandepilesy−relatedsyndromes} |
| WO2014142547A1 (en) * | 2013-03-12 | 2014-09-18 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compound and a composition for neuroprotection comprising the same |
| KR102900173B1 (ko) * | 2016-12-14 | 2025-12-12 | 에스케이바이오팜 주식회사 | 조현병, 강박장애 및 투렛증후군으로부터 선택되는 정신증 장애의 예방, 경감 또는 치료에 있어서의 카바메이트 화합물의 용도 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US278380A (en) * | 1883-05-29 | Thermometer | ||
| US3313692A (en) * | 1958-04-21 | 1967-04-11 | Armour Pharma | Method of inducing calming and muscle relaxation with carbamates |
| US3265728A (en) * | 1962-07-18 | 1966-08-09 | Armour Pharma | Substituted phenethyl carbamates |
| EP0480939B1 (en) * | 1989-06-09 | 1995-01-25 | The Upjohn Company | Heterocyclic amines having central nervous system activity |
| US5492930A (en) * | 1994-04-25 | 1996-02-20 | Schering Corporation | Method and formulation for treating CNS disorders |
| US5698588A (en) * | 1996-01-16 | 1997-12-16 | Yukong Limited | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
-
2002
- 2002-02-21 DK DK02707927T patent/DK1401424T3/da active
- 2002-02-21 HU HU0303342A patent/HUP0303342A3/hu unknown
- 2002-02-21 MX MXPA03007722A patent/MXPA03007722A/es active IP Right Grant
- 2002-02-21 RS YUP-675/03A patent/RS51056B/sr unknown
- 2002-02-21 AU AU2002242296A patent/AU2002242296B2/en not_active Ceased
- 2002-02-21 CZ CZ20032297A patent/CZ302412B6/cs not_active IP Right Cessation
- 2002-02-21 WO PCT/US2002/006119 patent/WO2002067927A1/en not_active Ceased
- 2002-02-21 EP EP02707927A patent/EP1401424B1/en not_active Expired - Lifetime
- 2002-02-21 ES ES02707927T patent/ES2275844T3/es not_active Expired - Lifetime
- 2002-02-21 AT AT02707927T patent/ATE346597T1/de active
- 2002-02-21 IL IL15758802A patent/IL157588A0/xx unknown
- 2002-02-21 RU RU2003128983/14A patent/RU2302240C2/ru active
- 2002-02-21 CN CNB028089235A patent/CN1262271C/zh not_active Expired - Fee Related
- 2002-02-21 PL PL02365021A patent/PL365021A1/xx unknown
- 2002-02-21 KR KR1020037011292A patent/KR100886578B1/ko not_active Expired - Lifetime
- 2002-02-21 NZ NZ527991A patent/NZ527991A/en unknown
- 2002-02-21 DE DE60216457T patent/DE60216457T2/de not_active Expired - Lifetime
- 2002-02-21 CA CA2439480A patent/CA2439480C/en not_active Expired - Fee Related
- 2002-02-21 JP JP2002567294A patent/JP4276841B2/ja not_active Expired - Lifetime
- 2002-02-21 BR BR0207829-5A patent/BR0207829A/pt not_active Application Discontinuation
- 2002-02-21 PT PT02707927T patent/PT1401424E/pt unknown
- 2002-02-21 US US10/081,761 patent/US6541513B2/en not_active Expired - Lifetime
- 2002-02-27 AR ARP020100702A patent/AR032876A1/es unknown
- 2002-03-05 TW TW091103972A patent/TWI251486B/zh not_active IP Right Cessation
-
2003
- 2003-08-26 IL IL157588A patent/IL157588A/en not_active IP Right Cessation
- 2003-08-26 NO NO20033801A patent/NO20033801L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP088179A (es) | Compuestos de carbamato para usarse en el tratamiento de desordenes neurodegenerativos | |
| JP2004527492A5 (cg-RX-API-DMAC7.html) | ||
| IL189003A0 (en) | Methods for treating substance-related disorders | |
| JP2007505877A5 (cg-RX-API-DMAC7.html) | ||
| JP2004517087A5 (cg-RX-API-DMAC7.html) | ||
| TW200508180A (en) | Therapeutic agents | |
| JP2011504903A5 (cg-RX-API-DMAC7.html) | ||
| JP2004525905A5 (cg-RX-API-DMAC7.html) | ||
| RU2010148762A (ru) | Тетразольные соединения для снижения концентрации мочевой кислоты | |
| JP2004533415A5 (cg-RX-API-DMAC7.html) | ||
| RU2003128984A (ru) | Производные карбаматов для использования для лечения боли | |
| MY157373A (en) | Carbamate compounds for use in preventing or treating movement disorders | |
| MY138156A (en) | Carbamate compounds for use in preventing or treating neurodegenerative disorders | |
| IL157589A (en) | Carbamate compounds for use in preventing or treating bipolar disorder | |
| EA200700642A1 (ru) | Способы лечения эпилептогенеза и эпилепсии | |
| IL157590A0 (en) | Carbamate compounds for use in preventing or treating bipolar disorder | |
| CA2439480A1 (en) | Carbamate compounds for use in preventing or treating psychotic disorders | |
| NO20072444L (no) | Karbamatforbindelser for anvendelse i behandling av neurodegenerative forstyrrelser | |
| WO2016077541A1 (en) | Novel anti-infective compounds and methods using same | |
| IL157594A0 (en) | Carbamate compounds for use in preventing or treating anxiety disorders | |
| JP2004517947A5 (cg-RX-API-DMAC7.html) | ||
| MX2007010787A (es) | Derivados de 1,2,4-triazinas, su preparacion y su aplicacion en terapia humana. | |
| JP2007507467A5 (cg-RX-API-DMAC7.html) | ||
| SE0400441D0 (sv) | Novel Benzofurans and Indols | |
| IL159847A0 (en) | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |